NIDA CTN-0031: Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement

The primary objective of this protocol is to evaluate the degree to which a combined group and individual 12-Step facilitative intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes compared to treatment as usual (TAU) without STAGE-12 among stimulant abusers.  For this protocol, STAGE-12 will be integrated into treatment as usual.  The primary objective is to evaluate reduction in percent of days of stimulant use as measured by self-report.  This is a randomized, 2-group design comparing STAGE-12 integrated into TAU (STAGE-12 /TAU) to TAU without STAGE-12 for stimulant abusers receiving formal substance abuse treatment in participating community-based treatment programs (CTP).  A total of approximately 450 stimulant users seeking formal treatment, recruited from 10 CTPS, will be randomized.

Part of the National Institute on Drug Abuse Clinical Trials Network. The Alcohol & Drug Abuse Institute serves as the Regional Research and Training Center (RRTC) of the Pacific Northwest Node. The Pacific Northwest Node was Co-Lead Node on this project.